Lifeline Biotechnologies ships first MastaScope to Greece


4 April, 2005. RENO, Nevada USA. Lifeline Biotechnologies, Inc. (OTC:LBTN) announced that its early breast cancer detection microendoscope system, the MastaScope, has been shipped to Greece.

The company says that it expects this initial shipment will lead to future sales as Greek doctors there begin to use the system with their patients and experience the high quality of visualization in the milk ducts where the majority of the breast cancers originate. MastaScope systems are being used in Egypt, Croatia, China and Puerto Rico, as well as the United States.

The Company also reported that management continues to explore business opportunities that can generate revenues as the company continues to carry out research and development of its premiere technology, the First Warning System, an early warning breast cancer detection system.


To top


To top